At Yoshindo, we are taking
on the challenge of a new future.

From high-quality generic medicines
to essential drugs for transfusion and dialysis,
and further, to the research and development of biopharmaceuticals.

Over the course of our long history, Yoshindo has made contributions to human health and social wellbeing through the manufacturing and sales of generic pharmaceutical products. We have developed a solid system of research and development, production, and sales that works consistently across all stages, from active pharmaceutical ingredients through to formulation. This has earned the company high levels of trust as a manufacturer of high-quality, low-cost generic medicines.

At present, we are advancing research and development into biopharmaceuticals and essential drugs for transfusion and dialysis. Utilizing our own research and development, we are building new technologies and know-how, with the aim of remaining an irreplaceable pharmaceutical company for Japan moving into the future.

Yoshindo is resolutely challenging itself in the development of new fields that surpass generic pharmaceuticals.

Corporate philosophy

Under the motto of “Creation and Trust”, we will be an irreplaceable pharmaceutical company by contributing to health of people and evolution of the community through development of high-quality pharmaceutical products and stable supply of the pharmaceutical products.

Quality policy

1. We will comply with relevant laws and ordinances with high ethical perspective to ensure the dissemination of compliance.
2. We will provide appropriate education to all employees to create a culture through which personnel with high level of quality awareness can be fostered.
3. We will accurately grasp the customer expectations and needs to develop products that always enable us to get the customers’ trust and make the customers satisfied.
4. We will perform unified management of the quality information in the processes from research and development, manufacture, through to the distribution and establish superior quality assurance system while continuously taking corrective actions and preventive actions.
5. We will implement management review periodically and invest our management resources to ensure stable supply of low-price but high-quality pharmaceutical products.